# Improving Function,Welfare of Late-stage Cancer Subjects by ACC

> **NCT03057314** · PHASE1 · TERMINATED · sponsor: **Amorphical Ltd.** · enrollment: 10 (actual)

## Conditions studied

- Solid Malignancies, With or Without Lung Metastases

## Interventions

- **DRUG:** Amorphous Calcium Carbonate

## Key facts

- **NCT ID:** NCT03057314
- **Lead sponsor:** Amorphical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-25
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow recreuitment
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03057314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03057314, "Improving Function,Welfare of Late-stage Cancer Subjects by ACC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03057314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*